These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37189717)

  • 41. [Expression of CD44 isoforms in normal human liver and also in regenerative and neoplastic liver changes].
    Seelentag WK; Flury R; Schmid M; Komminoth P; Saremaslani P; Günthert U; Heitz PU; Roth J
    Verh Dtsch Ges Pathol; 1995; 79():144-7. PubMed ID: 8600679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
    Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
    J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a Novel Anti-Mouse CCR6 Monoclonal Antibody (C
    Asano T; Tanaka T; Suzuki H; Li G; Nanamiya R; Tateyama N; Isoda Y; Okada Y; Kobayashi H; Yoshikawa T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Dec; 41(6):343-349. PubMed ID: 36383115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC).
    Mărgăritescu C; Pirici D; Simionescu C; Stepan A
    Rom J Morphol Embryol; 2011; 52(3 Suppl):985-93. PubMed ID: 22119814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a Sensitive Anti-Mouse CD39 Monoclonal Antibody (C
    Okada Y; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Feb; 43(1):24-31. PubMed ID: 38197855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production and characterization of a peptide-based monoclonal antibody against CD44 variant 6.
    Zarei S; Bayat AA; Hadavi R; Mahmoudi AR; Tavangar B; Vojgani Y; Jeddi-Tehrani M; Amirghofran Z
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):36-43. PubMed ID: 25723282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence.
    Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J
    Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitigation of delayed-type hypersensitivity reactions by a CD44 variant isoform v3-specific antibody: blockade of leukocyte egress.
    Seiter S; Engel P; Föhr N; Zöller M
    J Invest Dermatol; 1999 Jul; 113(1):11-21. PubMed ID: 10417612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
    Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
    Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin.
    Furusawa Y; Yamada S; Itai S; Nakamura T; Takei J; Sano M; Harada H; Fukui M; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2019 Jul; 18():100631. PubMed ID: 30984883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.
    Franzmann EJ; Weed DT; Civantos FJ; Goodwin WJ; Bourguignon LY
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):426-32. PubMed ID: 11283501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
    Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
    Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
    Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
    Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of specific anti-mouse atypical chemokine receptor 4 monoclonal antibodies.
    Hirose M; Suzuki H; Ubukata R; Tanaka T; Kaneko MK; Kato Y
    Biochem Biophys Rep; 2024 Dec; 40():101824. PubMed ID: 39290345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
    Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
    Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Establishment of a novel anti-TROP2 monoclonal antibody TrMab-29 for immunohistochemical analysis.
    Sayama Y; Kaneko MK; Takei J; Hosono H; Sano M; Asano T; Kato Y
    Biochem Biophys Rep; 2021 Mar; 25():100902. PubMed ID: 33490649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.